Vfend, Voriconazole (voriconazole) is a small molecule pharmaceutical. Voriconazole was first approved as Vfend on 2002-03-19. It is used to treat aspergillosis, candidiasis, fusariosis, and mycoses in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses.
|Indication||aspergillosis, bacterial infections and mycoses, candidiasis, fusariosis, mycoses|
|Drug Class||Systemic antifungals (miconazole type)|